ABVC BioPharma, Inc. (ECOC) Net margin 2018–2025
ABVC BioPharma, Inc. (ECOC) net profit margin by fiscal year — reported net income divided by reported revenue.
-2671.8%FY2025 · since FY2018: -87184.2% → -2671.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2671.8% | -1709.7 pp |
| FY2024 | -962.1% | +4147.1 pp |
| FY2023 | -5109.3% | -3415.8 pp |
| FY2022 | -1693.5% | +1915.0 pp |
| FY2021 | -3608.5% | -1415.4 pp |
| FY2020 | -2193.1% | -1632.6 pp |
| FY2019 | -560.5% | +86623.6 pp |
| FY2018 | -87184.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice